New study aims to track dangerous infections in kids with sickle cell disease
NCT ID NCT07639008
First seen Jun 17, 2026 · Last updated Jun 19, 2026 · Updated 1 time
Summary
This study will look at medical records of 350 children with sickle cell disease in France who had serious bacterial infections between 2020 and 2025. The goal is to find out which bacteria are causing these infections today, especially with new vaccines available. The results could help improve prevention and treatment for these children.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE (SCD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CH Gonesse
Gonesse, France
Contact
-
CH Rambouillet
Rambouillet, France
Contact
-
CH Rives de Seine, Site de Neuilly-sur-Seine
Neuilly-sur-Seine, France
Contact
-
CH Saint Denis, Hôpital Delafontaine
Saint-Denis, France
Contact
-
CH Sud Francilien
Corbeil-Essonnes, France
Contact
-
CH du Sud Seine et Marne
Fontainebleau, France
Contact
-
CHI Créteil
Créteil, France
Contact
-
CHI Poissy
Poissy, France
Contact
-
CHI Robert Ballanger
Aulnay-sous-Bois, France
Contact
-
CHU Lenval
Nice, France
Contact
-
CHU Nantes
Nantes, France
Contact
-
GH Sud Ile-de-france
Melun, France
Contact
-
GHEF, Site de Marne-la-Vallée
Jossigny, France
Contact
-
GHEF, Site de Meaux
Meaux, France
Contact
-
GHI Le Raincy-Montfermeil
Montfermeil, France
Contact
-
GHT Yvelines Nord
Mantes-la-Jolie, France
Contact
-
Hôpital Ambroise Paré
Boulogne-Billancourt, France
Contact
-
Hôpital André Mignot
Versailles, France
Contact
-
Hôpital Antoine Béclère
Clamart, France
Contact
-
Hôpital Bicêtre
Le Kremlin-Bicêtre, France
Contact
-
Hôpital Intercommunal Villeneuve-St-Georges
Villeneuve-Saint-Georges, France
Contact
-
Hôpital Jean Verdier
Bondy, France
Contact
-
Hôpital NOVO
Cergy-Pontoise, France
Contact
-
Hôpital Necker
Paris, France
Contact
-
Hôpital Nord, AP-HM
Marseille, France
Contact
-
Hôpital Paris-Saclay
Orsay, France
Contact
-
Hôpital Pellegrin - Hôpital des Enfants
Bordeaux, France
Contact
-
Hôpital Robert Debré
Paris, France
Contact
-
Hôpital Saint Camille
Bry-sur-Marne, France
Contact
-
Hôpital Trousseau
Paris, France
Contact
-
Hôpital Victor Dupouy (CH Argenteuil)
Argenteuil, France
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better understand which bacteria cause serious infections in children with sickle cell disease, leading to improved vaccines and prevention plans.
What could go wrong
This is an observational study that only looks at past data, so it cannot test new treatments or prove what works best. The findings may not apply to children outside France.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.